Cancer of unknown primary origin classification: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Cancer of unknown primary origin}} | {{Cancer of unknown primary origin}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}, {{RAK}} | ||
==Overview== | ==Overview== | ||
Cancer of unknown primary origin may be classified into 4 groups initially according to [[light microscopy]] of the [[biopsy]] including [[Adenocarcinoma|Adenocarcinomas]] | Cancer of unknown primary origin may be classified into 4 groups initially according to [[light microscopy]] of the [[biopsy]] including [[Adenocarcinoma|Adenocarcinomas]], [[Squamous cell carcinoma|Squamous cell carcinomas]], Poorly differentiated tumors, and [[Neuroendocrine tumor|Carcinomas with neuroendocrine differentiation]]. | ||
==Classification== | ==Classification== | ||
| Line 57: | Line 55: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WS}} | {{WS}} | ||
[[Category: (name of the system)]] | [[Category: (name of the system)]] | ||
Revision as of 20:49, 6 February 2019
|
Cancer of unknown primary origin Microchapters |
|
Differentiating Cancer of Unknown Primary Origin from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cancer of unknown primary origin classification On the Web |
|
American Roentgen Ray Society Images of Cancer of unknown primary origin classification |
|
Risk calculators and risk factors for Cancer of unknown primary origin classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Roukoz A. Karam, M.D.[2]
Overview
Cancer of unknown primary origin may be classified into 4 groups initially according to light microscopy of the biopsy including Adenocarcinomas, Squamous cell carcinomas, Poorly differentiated tumors, and Carcinomas with neuroendocrine differentiation.
Classification
- Cancer of unknown primary origin may be classified into 4 groups initially according to light microscopy of the biopsy:[1]
- Adenocarcinomas
- Squamous cell carcinomas
- Poorly differentiated tumors
- Carcinomas with neuroendocrine differentiation
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [Group1]
- [Group2]
- [Group3]
- [Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
[Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].